389470 — Inventage Lab Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual income statement for Inventage Lab, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,862	3,724	658	1,783	2,939
Cost of Revenue
Gross Profit	1,627	3,322	584	1,754	-2,942
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	11,420	14,625	16,551	20,747	24,951
Operating Profit	-9,558	-10,902	-15,893	-18,964	-22,012
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-9,271	-10,595	-26,994	-19,185	-13,689
Provision for Income Taxes
Net Income After Taxes	-9,271	-10,595	-26,994	-16,997	-15,911
Minority Interest
Net Income Before Extraordinary Items
Net Income	-9,271	-10,595	-26,994	-16,997	-8,458
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-9,271	-10,595	-26,994	-16,997	-8,458
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,165	-1,457	-3,146	-1,854	-1,141
Dividends per Share